STARTUP MASTERY | Design with the Payer in Mind

Proving your technology works is only half the battle. For early-stage life science, medical device, and digital health startups, the ultimate bottleneck is surviving the long, capital-intensive road between regulatory clearance and real commercial adoption. To build a venture that lasts, founders must design for reimbursement pathways, payer mechanics, and clear monetization strategies from day one.

This installment of Startup Mastery moves past abstract theory to deliver actionable blueprints for keeping your venture capitalized and bankable throughout the regulatory lifecycle.

WHAT WE'LL COVER

• The Dual-Track & Consumer-First Approach: Learn how to de-risk your venture by commercializing IP through accessible, consumer-facing models to generate immediate cash flow and market traction while advancing formal clinical validation.
• The Cross-Sector Validation Bridge: Discover how founders bypass the traditional payer gauntlet by launching first in secondary markets—such as animal health—to build revenue, gather data, and create a sustainable runway for human clinical applications.
• The Payer Mindset & Reimbursement Blueprint: Pull back the curtain on what institutional insurers actually prioritize. Learn how to design clinical trials that meet payer expectations, bridge the gap between FDA clearance and reimbursement activation, and strategically navigate the CPT coding process.

KEY TAKEAWAYS

• How to build early commercialization runways long before facing market bottlenecks.
• Proven frameworks to translate clinical efficacy into institutional payer adoptability.
• Actionable strategies to align trial design with billing codes, reimbursement policies, and investor expectations.

MEET THE SPEAKERS

• Ryan Callahan is an expert in digital health and healthcare reimbursement who works with healthcare companies of all sizes as a commercialization partner, angel investor, and strategic advisor. He is a Senior Director and Head of US for Prova Health, a London-based consultancy that focuses on overcoming real-world adoption challenges through purpose-built evidence strategies and assets. Ryan previously led a startup tech company selling into US health systems as President of Orthos. Ryan began his career as a consultant to the hospital and life sciences sectors at McKinsey & Company. He has worked in the US, UK, Australia, West Africa, and Singapore and is based in South Bend, Indiana.
• Travis Block is CEO and Founder of GoldiloxBio, Inc., a biotechnology company developing next-generation human tissue models to improve the drug development process. GoldiloxBio is addressing a fundamental challenge in pharmaceutical development: despite billions of dollars spent annually, the vast majority of drug candidates fail in clinical trials. A significant driver of this inefficiency is the lack of predictive preclinical models, which often fail to accurately replicate human biology.
• Dr. Alex Crawford is a veteran biotech entrepreneur with over two decades of experience building and scaling pharmaceutical and drug development companies, including previously serving as the CEO of Mermaid Pharmaceuticals. His latest venture is Arylium, a stealth-mode biotech startup focused on leveraging advanced technologies to drive innovation in animal and human drug development.

Event venue & nearby stays

Launch Fishers, 12175 Visionary Way, Fishers, United States

Concerts, fests, parties, meetups — all the happenings, one place.

Get the app →

Discover more events by tag